Biogen Idec Inc (NASDAQ:BIIB)

294.84
Data as of Apr 24
 -11.91 / -3.88%
Today’s Change
194.66
Today|||52-Week Range
358.89
+5.46%
Year-to-Date
Why Xilinx Inc., Biogen Idec Inc., and Qualcomm Incorporated Are Todaybs 3 Worst Stoc...
Apr 24 / MotleyFool.com
Trading Radar for 04/23: Apple (AAPL), Facebook (FB), TI (TXN), Zynga (ZYNGA), Boeing...
Apr 22 / Investing Channel
Spectrum Pharma Candidate Gets Positive Data - Analyst Blog
Apr 24 / Zacks.com
Scoping the Earnings Trades
Apr 22 / TheStreet.com
Why Investors Should Love Biogen's Earnings Miss
Apr 24 / MotleyFool.com
Biotech Earnings Preview
Apr 22 / MotleyFool.com
Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns
Apr 24 / Benzinga
Keep an Eye on these 3 Biotech Stocks - Earnings ESP
Apr 22 / Zacks.com
3 Drugs Stocks Dragging The Industry Down
Apr 24 / TheStreet.com
Alexion Likely to Keep Earnings Streak Alive - Analyst Blog
Apr 22 / Zacks.com
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity...
Apr 24 / Zacks.com
Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders
Apr 22 / TheStreet.com
Stock Market News for April 24, 2014 - Market News
Apr 24 / Zacks.com
Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape
Apr 22 / Zacks.com
Earnings Roundup: Biogen's Tecfidera Wins More Share
Apr 24 / MotleyFool.com
ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape
Apr 22 / Zacks.com
Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape
Apr 24 / Zacks.com
Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape
Apr 22 / Zacks.com
Ambit Biosciences Slumps: AMBI Falls 7.1% in Session - Tale of the Tape
Apr 24 / Zacks.com
Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog
Apr 21 / Zacks.com
Quintiles, Biogen Idec Announce Comprehensive Clinical Development Partnership
Apr 24 / Benzinga
What to Watch for in Biotech Earnings This Week
Apr 21 / MotleyFool.com
Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces 7-for-1 Stock ...
Apr 23 / Benzinga
Biogen Idec Inc (BIIB): Planning An April Pivot Trade
Apr 21 / Investing Channel
Miracle Drug May Be Ailing Gilead
Apr 23 / TheStreet.com
Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog
Apr 21 / Zacks.com
Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog
Apr 23 / Zacks.com
3 Stocks Reiterated As A Buy: MU, VZ, BIIB
Apr 21 / TheStreet.com
Why Biogen (BIIB) Stock Is Down Today
Apr 23 / TheStreet.com
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Co...
Apr 21 / Benzinga
Interesting BIIB Put And Call Options For June 21st
Apr 23 / TheStreet.com
AbbVie Candidate in Pivotal Study - Analyst Blog
Apr 17 / Zacks.com
Amgen's Q1 Earnings Decline Y/Y - Analyst Blog
Apr 23 / Zacks.com
Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Apr 17 / MotleyFool.com
Revance Therapeutics (RVNC) Soars: Stock Up 25.8% - Tale of the Tape
Apr 23 / Zacks.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data -...
Apr 16 / Zacks.com
Why Biogen Idec (BIIB) Might Surprise This Earnings Season - Tale of the Tape
Apr 23 / Zacks.com
3 Biotech Opportunities Following This Selloff
Apr 16 / MotleyFool.com
Strong Upward Pre-Market Activity For Biogen Idec (BIIB)
Apr 23 / TheStreet.com
Health Care Stocks: Check Out This Low-Cost Market Beater
Apr 15 / MotleyFool.com
Earnings Scheduled For April 23, 2014
Apr 23 / Benzinga
Biotech Bubble Bust: 2 Ways to Win
Apr 15 / MotleyFool.com
'Fast Money' Recap: Riding the Momentum
Apr 23 / TheStreet.com
Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog
Apr 15 / Zacks.com
Is Biogen (BIIB) Poised to Beat Earnings Estimates? - Analyst Blog
Apr 22 / Zacks.com
Are Biotechs Bad Medicine for the S&P 500?
Apr 15 / MotleyFool.com
Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog
Apr 22 / Zacks.com
Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog
Apr 14 / Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Health Care Winner
Apr 22 / TheStreet.com
Stock Market News for April 14, 2014 - Market News
Apr 14 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.